Andrew Guy Windham

Irish Stock Exchange Ltd. lists debt and fund securities. The firm’s products and services include listing debts, quoted companies, listing funds, listing ETFs, trading members, sponsors and advisors, information services, LEI services, ISIN and CFI services, announcement services and IPOready programme. The company was founded in 1793 and is headquartered in Dublin, Ireland.

Riada Stockbrokers Ltd provides brokerage services. The private company is based in Dublin, Ireland.

The Society of Exploration Geophysicists operates as an association of exploration geophysicists. The non-profit company is based in Tulsa, OK and has subsidiaries in the United States.

Part of Barryroe Offshore Energy Plc, Providence Resources UK Ltd. is a company based in London, UK. The British company was founded in 1965.

Blackstairs Energy Plc engages in the oil and gas exploration and production services. The company was founded by Gerry Sheehan and Robert Hamilton and is headquartered in Dublin, Ireland.

Raglan Capital Ltd. is an Irish company that specializes in creating in-house companies for rapid listing on the London Stock Exchange. Raglan Capital aims to create one new company per year and achieve an IPO within three years. The private company has offices in Ireland, the UK, and the US. The company's portfolio includes companies such as Poolbeg Pharma, HVIVO, Amryt Pharma, Fastnet Oil & Gas, and European Green Metals. The company was founded in 2007 by Cathal Martin Friel, who has been the CEO since incorporation.

PrEP Biopharm Ltd. develops and manufactures biopharmaceutical products. The British company was founded in 2015 by Ryan Muldoon and Bruce A. Malcolm. Ryan Muldoon has been the CEO since 2015.

Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom.

Open Orphan DAC develops platform for pharmaceutical and biotechnology companies seeking to commercialize their products across Europe. It focuses on building its database of over 500 pharmaceutical companies with orphan drugs either approved or advancing through clinical trials. The company is headquartered in Ballsbridge, Ireland.